Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Krishna Vaddi currently holds 837,000 shares of Prelude Therapeutics Inc (PRLD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Krishna Vaddi has been a net buyer of PRLD stock. They have purchased $175.0K and sold $0 worth of shares.
Krishna Vaddi's most recent insider trade was on Feb 4, 2026, when they sold 837,000 shares at $0.00 per share.
Krishna Vaddi serves as Executive at Prelude Therapeutics Inc (PRLD). They have executed 10 insider transactions totaling $175.0K over their tenure at the company.
Krishna Vaddi holds the position of Executive at Prelude Therapeutics Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Krishna Vaddi has shown a buying trading pattern, with $175.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Krishna Vaddi was on Dec 20, 2022, when they purchased $98.4K worth of PRLD shares. This transaction involved 19,188 shares at $5.13 per share.
Krishna Vaddi currently owns 837,000 shares of Prelude Therapeutics Inc (PRLD), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Krishna Vaddi's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Krishna Vaddi has 10 Form 4 filings on record as an insider at Prelude Therapeutics Inc.
Set alerts for Krishna Vaddi and 40,000+ other insiders.